Pre-operative redox state affects 1-month survival in patients with advanced heart failure undergoing left ventricular assist device implantation
Articolo
Data di Pubblicazione:
2007
Citazione:
Pre-operative redox state affects 1-month survival in patients with advanced heart failure undergoing left ventricular assist device implantation / R. Caruso, A. Garatti, V. Sedda, F. Milazzo, J. Campolo, T. Colombo, E. Catena, G. Cighetti, C. Russo, M. Frigerio, E. Vitali, O. Parodi. - In: THE JOURNAL OF HEART AND LUNG TRANSPLANTATION. - ISSN 1053-2498. - 26:11(2007 Nov), pp. 1177-1181.
Abstract:
BACKGROUND: Left ventricular assist device (LVAD) implantation has proven effective as a bridge to transplantation in end-stage heart failure patients (ESHFPs), although survival during device support is critical. Oxidative stress has been implicated in the development of heart failure, but the influence of redox state on in-hospital post-LVAD outcome has not been clarified. METHODS AND RESULTS: In this report we describe the oxidant/anti-oxidant profiles of 15 ESHFPs before LVAD placement, 5 of whom did not survive to 1 month, and in 30 subjects without cardiac disease, representing the control group. CONCLUSIONS: Preliminary findings suggest that adequate activity of the GPx-1-based anti-oxidant system before device placement is associated with patient survival up to 1 month, despite comparable baseline oxidative stress in patients who both survived and died (within 2 weeks post-LVAD)
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
R. Caruso, A. Garatti, V. Sedda, F. Milazzo, J. Campolo, T. Colombo, E. Catena, G. Cighetti, C. Russo, M. Frigerio, E. Vitali, O. Parodi
Link alla scheda completa: